16 February 2025 - Oral Presentation Free Paper

16 Feb 2025 10:30 12:00

Sipadan 1

Mohamed Rezal bin Abdul Aziz Moderator

Time	Session

10:30 10:42	The CREAFORMO-004 study: A phase II study of HR070803 plus 5-fluoruracil/leucovorin and bevacizumab as second-line treatment in patients with metastatic colorectal cancer AB-0099 Jianling Zou Presenter
10:54 11:06	Triplet chemoradiotherapy with paclitaxel for squamous-cell anal cancer: a phase III trial AB-0016 Sergey Gordeyev Presenter
11:06 11:18	Purse string Ileostomy Closure with NegatIve Pressure Wound Therapy: a Prospective Cohort Study in Patients Undergoing Stoma Closure Compared to a Retrospective Cohort Study AB-00130 Carolyn Chew Presenter
11:18 11:30	Unpacking Empty Pelvis Syndrome: Risk Factors and Reconstruction Outcomes After Pelvic Exenteration AB-0073 James Lockhart Presenter
11:30 11:42	Value of pre-operative endoscopy and magnetic resonance imaging in predicting pathological complete response in patients with rectal cancer following neoadjuvant therapy AB-0087 Trevor Yeung Presenter